Sylvain Lamoine

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

Laura Poupon, Sylvain Lamoine, Vanessa Pereira et al. · Neuropharmacology · 2018 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

Vanessa Pereira, Sylvain Lamoine, Mélissa Cuménal et al. · Molecular Neurobiology · 2021 · 21 citations

Life Sciences, Cancer Biology, Molecular Biology +14

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

Sylvain Lamoine, Mélissa Cuménal, David André Barrière et al. · International Journal of Molecular Sciences · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain

Sophie L. Fayad, Guillaume Ourties, Benjamin Le Gac et al. · eLife · 2022 · 16 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats

Nazarine Mokhtar, Marcin Drop, Florian Jacquot et al. · Biomolecules · 2023 · 12 citations · Full text

Medicine, Neuroscience, Pharmacology +17